Cell and gene therapies have become cutting-edge treatments for a wide range of illnesses, such as cancer, genetic disorders, and autoimmune diseases. These treatments aim to treat or prevent disease by altering or replacing a patient's genetic makeup or cells. While this sector has witnessed tremendous growth over the last few years because of increasing interest from industry and academia, it still faces challenges in clinical trials, such as regulatory requirements, manufacturing complexity, and patient recruitment.
This resource provides information on the current global landscape of clinical trials for cell and gene therapy, an overview of the major players in the cell and gene therapy space, and the various approaches to develop and commercialize these therapies. Access the article to gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.